Development of next-generation immunomodulatory antibodies for cancer therapy through optimization of the IgG framework
Development of next-generation immunomodulatory antibodies for cancer therapy through optimization of the IgG framework
273-275
Offringa, R.
35c22b3b-9c5b-4637-afb2-bf09f986ae0b
Glennie, M.
9f6f0eff-4560-48c2-80cd-0ec116110ded
14 September 2015
Offringa, R.
35c22b3b-9c5b-4637-afb2-bf09f986ae0b
Glennie, M.
9f6f0eff-4560-48c2-80cd-0ec116110ded
Offringa, R. and Glennie, M.
(2015)
Development of next-generation immunomodulatory antibodies for cancer therapy through optimization of the IgG framework.
Cancer Cell, 28 (3), .
(doi:10.1016/j.ccell.2015.08.008).
(PMID:26373272)
This record has no associated files available for download.
More information
Published date: 14 September 2015
Organisations:
Cancer Sciences
Identifiers
Local EPrints ID: 390373
URI: http://eprints.soton.ac.uk/id/eprint/390373
ISSN: 1535-6108
PURE UUID: aab6d8d5-95d0-4152-a23d-e101002bdd3a
Catalogue record
Date deposited: 31 Mar 2016 14:48
Last modified: 14 Mar 2024 23:17
Export record
Altmetrics
Contributors
Author:
R. Offringa
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics